Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model
β Scribed by M. Roggendorf; I. Schulte; Y. Xu; M. Lu
- Book ID
- 108886068
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 152 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Woodchucks were used to study the antiviral activity and toxicity of fialuridine (FIAU; 1,-2'deoxy-2'fluoro-1-beta-D-arabinofuranosyl-5-iodo-uracil). In an initial experiment, groups of six chronic woodchuck hepatitis virus (WHV) carrier woodchucks received daily doses of FIAU by intraperitoneal inj
## Abstract Apolipoprotein AβI (ApoAβI) is the major protein component of high density lipoprotein (HDL) particles in serum, and participates in the reverse transport of cholesterol from tissues to the liver for excretion. The natural HDL tropism to the liver and cancer cells has been used extensiv
## Abstract There are several lines of evidence suggesting that specific vaccine therapy with a standard hepatitis B virus (HBV) vaccination reduces HBV replication. The aim of this study was to investigate the antiβviral mechanism of vaccine therapy in chronic hepatitis B patients. Nineteen patien
Hepatitis B virus (HBV) mutants resistant to treatment with nucleoside or nucleotide analogs and those with the ability to escape from HBV-neutralizing antibody have the potential to infect HBV-vaccinated individuals. To address this potential serious public health challenge, we tested the efficacy